Clinical Trial

A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

Name: A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A — clinical trial record (NCT07226206)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study will assess the safety and tolerability of SPK-8011QQ in adult males with moderately severe to severe hemophilia A.

Protocol Amendment History 2 changes

critical Recruitment opened 2026-04-28

critical Trial status changed: Recruiting → Not Yet Recruiting 2026-04-01

Trial Details

NCT Number	NCT07226206
Lead Sponsor	Hoffmann-La Roche
Conditions	Hemophilia A
Enrollment	5 participants
Start Date	2026-09-01
Primary Completion	2031-07-31 (estimated)
Study Completion	2031-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-04